Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn

Page 8 of 8

1. Viatris Inc. (NASDAQ:VTRS)

Greenlight Capital’s Equity Stakes: $72.02 Million

Number of Hedge Fund Holders: 48

Viatris Inc. (NASDAQ:VTRS) is a healthcare company that offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various categories, boasting a portfolio of more than 1,400 approved molecules. It also offers high-quality generic and branded medicines in over 165 countries, affirming its status as one of the top healthcare stocks in David Einhorn’s portfolio.

In a bid to strengthen its long-term prospects and growth metrics, Viatris Inc. (NASDAQ:VTRS) is in the process of developing a generic version of Novo Nordisk’s famous weight loss drugs, Ozempic AND Wegovy. The push is part of the company’s bid to unlock growth opportunities in the multibillion weight loss market.

Viatris Inc. (NASDAQ:VTRS) reported $14.7 billion in total revenue, $4.7 billion in adjusted EBITDA and $2 billion in free cash flow for its fiscal 2024. For 2025, the company is prioritizing capital return and expects to return between $500 million and $650 million through stock buybacks.

While we acknowledge the potential of Viatris Inc. (NASDAQ:VTRS), our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than VTRS but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 8 of 8